Biological features of ductal carcinoma in situ: clinical role and basis for treatment individualization
Ductal carcinoma in situ (DCIS) is an extremely heterogeneous disease in terms of clinical manifestations, morphological changes, and expression of biomarkers, which determine the risk of subsequent development of an invasive breast cancer (BC). Diagnosis and treatment of DCIS prevents the developme...
Guardado en:
Autores principales: | Irina V. Kolyadina, Anastasia S. Butrimova, Irina V. Poddubnaya, Vlada V. Kоmetova, Valery V. Rodionov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e4ad4f21c5f4565a41b3d1f362f66f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FACTORES PRONÓSTICOS DEL CARCINOMA DUCTAL IN SITU DE MAMA
por: Martínez RM,Alejandra, et al.
Publicado: (2008) -
Carcinoma in situ dentro de un fibroadenoma de mama: Tres casos clínicos
por: TAPIA N,GRACE, et al.
Publicado: (2008) -
Prognostic Factors and a Nomogram Predicting Survival in Patients with Breast Ductal Carcinoma in situ with Microinvasion: A Population-Based Study
por: Zheng YZ, et al.
Publicado: (2021) -
Prophylactic mastectomy for the prevention of breast cancer: Review of the literature
por: Rawan K. Alaofi, et al.
Publicado: (2018) -
Ductal Carcinoma in situ: Underestimation of Percutaneous Biopsy and Positivity of Sentinel Lymph Node Biopsy in a Brazilian Public Hospital
por: Sá RS, et al.
Publicado: (2021)